Compared with a statin alone, the addition of Praluent cost $308 000 per quality-adjusted life year (QALY) gained. But the addition of ezetimibe cost $81 000 per QALY compared with a statin alone.

Both Repatha and Praluent are priced around $14,000, but currently lack data to prove they can prevent heart attacks and stroke. Andrew McConaghie 23 March, 2016 ...

Clinical Lipid Management;455a] Alirocumab (Praluent, Regeneron ... (including HeFH): Either 75 mg once every 2 weeks or 300 mg once every 4 weeks, administered subcutaneously.